Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-18-001166
Filing Date
2018-05-25
Accepted
2018-05-24 19:03:25
Documents
7
Period of Report
2018-05-24

Document Format Files

Seq Description Document Type Size
1 FORM 6-K essa6k.htm 6-K 13831
2 MCR DATED JANUARY 15, 2016 ex991.htm EX-99.1 9888
3 MCR DATED JANUARY 19, 2018 ex992.htm EX-99.2 22188
4 MCR DATED FEBRUARY 5, 2018 ex993.htm EX-99.3 12983
5 MANAGEMENT INFORMATION CIRCULAR ex994.htm EX-99.4 910477
6 GRAPHIC image_logo.jpg GRAPHIC 47429
7 GRAPHIC image_002.jpg GRAPHIC 56812
  Complete submission text file 0001279569-18-001166.txt   1114210
Mailing Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (778) 331-0962
ESSA Pharma Inc. (Filer) CIK: 0001633932 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 6-K | Act: 34 | File No.: 001-37410 | Film No.: 18859253
SIC: 2834 Pharmaceutical Preparations